Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MTL Cannabis Corp C.MTLC

Alternate Symbol(s):  MTLNF

MTL Cannabis Corp. is focused on crafting cannabis products, including lines of dried flower, pre-rolls and hash marketed. The Company, through its subsidiaries, is engaged in the cultivation and production of cannabis products for recreational and medical purposes in Canada. It also operates clinics that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from medical conditions. Its wholly owned subsidiaries include Montreal Medical Cannabis Inc. (Montreal Cannabis), Abba Medix Corp. (Abba), Canada House Clinics Inc. (CHC), and IsoCanMed Inc. (ICM). Montreal Medical is a licensed producer operating from a 57,000 sq ft licensed indoor growing facility in Pointe Claire, Quebec. Abba is a licensed producer in Pickering, Ontario that operates a medical cannabis marketplace. CHC is operating clinics across Canada. ICM is a licensed producer in Louiseville, Quebec growing indoor cannabis in its 64,000 sq. ft. production facility.


CSE:MTLC - Post by User

Bullboard Posts
Comment by blackgold909on Apr 10, 2017 9:44am
69 Views
Post# 26099684

RE:CMM A MUCH BETTER "GAMBLE" ....

RE:CMM A MUCH BETTER "GAMBLE" .... CANABO MEDICAL INC.
Unaudited Condensed Interim Consolidated Statements of Comprehensive Loss
For the periods ended January 31, 2017 and 2016
(Expressed in Canadian dollars)

Revenue - 3 months ended Jan 31,2017 - $858,661
Cost of Sales                                           - $385,640
Expenses                                                - $4,041,731

Net Loss and Comprehensive Loss        ($3,568,710)

So lets compare value here of CMM and CHV

CHV reported revenue of $1.7mln for the same 3 months ending Jan 31,2017

CHV is a late stage pending Licensed Producer awaiting Health Canada Inspection - 14,500 sq foot facility
that is virtually complete.  Last week we saw Canopy acquire a late stage applicant for $37mln.  You tell me
where the better value is?
Bullboard Posts